Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Pollen Allergenic Extract [EPC]
Phleum Pratense Top is a standardized allergenic extract derived from Timothy Grass pollen, primarily used in allergen immunotherapy to treat seasonal allergic rhinitis. It belongs to the class of standardized pollen allergenic extracts and works by inducing immunological tolerance.
Name
Phleum Pratense Top
Raw Name
PHLEUM PRATENSE TOP
Category
Standardized Pollen Allergenic Extract [EPC]
Drug Count
5
Variant Count
6
Last Verified
February 17, 2026
About Phleum Pratense Top
Phleum Pratense Top is a standardized allergenic extract derived from Timothy Grass pollen, primarily used in allergen immunotherapy to treat seasonal allergic rhinitis. It belongs to the class of standardized pollen allergenic extracts and works by inducing immunological tolerance.
Detailed information about Phleum Pratense Top
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Phleum Pratense Top.
Phleum Pratense Top is the standardized allergenic extract derived from the pollen of Phleum pratense, commonly known as Timothy Grass. This agent is a cornerstone of allergen immunotherapy (AIT), a clinical process designed to reduce the sensitivity of patients to specific allergens. Phleum Pratense Top belongs to the pharmacological class of Standardized Pollen Allergenic Extracts [EPC]. In the regulatory landscape, it is often cross-referenced with various allergenic categories, including non-standardized food and animal extracts, due to the complex nature of cross-reactivity and the standardized protocols used in diagnostic and therapeutic allergy medicine.
Historically, Timothy Grass has been identified as one of the most prevalent causes of seasonal allergic rhinitis (hay fever) across North America and Europe. The FDA approval of standardized extracts like Phleum Pratense Top marked a significant shift from symptom management (using antihistamines and corticosteroids) to disease-modifying therapy. By exposing the patient to controlled, increasing amounts of the very substance that triggers their allergies, Phleum Pratense Top aims to reprogram the immune system's response. This treatment is typically indicated for patients who have a confirmed clinical history of Timothy Grass-induced allergic rhinitis and have demonstrated sensitivity via skin prick testing or in vitro testing for pollen-specific IgE antibodies.
The mechanism of action of Phleum Pratense Top is rooted in the modulation of the human immune system, specifically the shift from a Th2-dominated allergic response to a Th1-dominated or regulatory T-cell (Treg) response. At the molecular level, the extract contains specific proteins, most notably Phl p 1 and Phl p 5, which are the major allergens responsible for the majority of clinical symptoms in grass-allergic individuals.
When administered sublingually (under the tongue) or subcutaneously (via injection), Phleum Pratense Top interacts with dendritic cells in the mucosa or skin. These cells process the allergens and present them to T-lymphocytes. Over time, this repeated exposure leads to the production of 'blocking antibodies,' specifically Immunoglobulin G4 (IgG4) and Immunoglobulin A (IgA). These antibodies compete with Immunoglobulin E (IgE) for binding sites on the allergen. By preventing the allergen from cross-linking IgE on the surface of mast cells and basophils, the extract inhibits the release of inflammatory mediators like histamine, leukotrienes, and cytokines. Furthermore, the treatment induces the expansion of regulatory T-cells that secrete IL-10 and TGF-beta, which suppress the allergic inflammatory cascade. Interestingly, while the primary therapeutic effect is immunological, the extract is often categorized alongside Adrenergic alpha-Agonists and beta-Agonists [MoA] in pharmacological databases because the physiological management of its most severe potential side effect—anaphylaxis—requires the immediate activation of these receptors via epinephrine.
Unlike traditional small-molecule drugs, the pharmacokinetics of allergenic extracts like Phleum Pratense Top are not measured through traditional blood concentration levels of the active ingredient, as the 'active' components are proteins that act locally on the immune system.
Phleum Pratense Top is FDA-approved for the treatment of grass pollen-induced allergic rhinitis, with or without conjunctivitis (eye allergies), in adults and children (typically ages 5 through 65, depending on the specific brand/formulation).
Phleum Pratense Top is available in several specialized delivery formats designed for immunotherapy:
> Important: Only your healthcare provider can determine if Phleum Pratense Top is right for your specific condition. A confirmed diagnosis via allergy testing is required before starting treatment.
For adult patients (18 to 65 years of age), the standard dosage of Phleum Pratense Top in its sublingual tablet form is typically one tablet (standardized to approximately 2800 Bioequivalent Allergen Units or BAU) taken once daily.
Phleum Pratense Top is approved for use in children as young as 5 years of age.
There are no specific dosage adjustments provided for patients with renal impairment. Because the allergenic proteins are metabolized locally and are not cleared primarily by the kidneys in their active form, significant accumulation is not expected. However, caution is advised in patients with severe renal disease who may have a compromised ability to handle systemic anaphylaxis.
No dosage adjustments are required for patients with hepatic impairment. The metabolic pathway of Phleum Pratense Top does not involve hepatic CYP450 enzymes.
Clinical trials included a limited number of patients over age 65. While no specific dosage adjustment is required, the decision to treat should consider the patient's overall health and their ability to tolerate a potential systemic reaction or use an epinephrine auto-injector.
If a dose is missed, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose to catch up. If more than one dose is missed, contact your healthcare provider, as you may need to restart the treatment under medical supervision if the gap is significant.
Signs of overdose may include severe local reactions (swelling of the tongue or throat) or systemic allergic reactions (hives, abdominal pain, difficulty breathing). In the event of an accidental overdose, seek emergency medical attention immediately. Treatment is supportive and may involve the administration of antihistamines or epinephrine depending on the severity of the symptoms.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or stop treatment without medical guidance, as this can affect both safety and efficacy.
Most patients taking Phleum Pratense Top will experience local reactions at the site of administration, especially during the first week of treatment. These are generally mild to moderate and include:
> Warning: Stop taking Phleum Pratense Top and call your doctor or emergency services immediately if you experience any of the following:
Phleum Pratense Top is generally well-tolerated over long periods (3+ years). The most significant long-term concern is the development of Eosinophilic Esophagitis. Patients who develop persistent heartburn, difficulty swallowing (dysphagia), or food impaction should be evaluated by a gastroenterologist. On the positive side, a long-term 'side effect' is the potential for a permanent reduction in allergy symptoms and a decreased risk of developing asthma.
Report any unusual symptoms to your healthcare provider immediately. Local reactions often diminish after the first 1-2 weeks of consistent use.
Phleum Pratense Top is a potent biological extract. Its use requires careful patient selection and education. The most critical safety consideration is the risk of systemic allergic reactions. Patients must be capable of recognizing the early signs of anaphylaxis and must be willing and able to use an epinephrine auto-injector if necessary. Treatment should be postponed if the patient has an acute infection, oral inflammation (such as mouth sores or thrush), or has recently undergone oral surgery (including tooth extraction).
Phleum Pratense Top carries an FDA Black Box Warning regarding the risk of severe allergic reactions. The warning emphasizes that Phleum Pratense Top can cause anaphylaxis, which may be fatal. Because of this risk, the first dose must be given in a medical facility where the patient can be monitored for 30 minutes. Patients with uncontrolled asthma are at a significantly higher risk for fatal outcomes and should not use this medication. All patients must be prescribed an epinephrine auto-injector (e.g., EpiPen) and must be trained on how to use it before beginning home therapy.
While there are no specific blood tests (like liver or kidney function tests) required for Phleum Pratense Top, clinical monitoring is essential:
Phleum Pratense Top does not typically cause sedation or cognitive impairment. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have been cleared by a medical professional.
There is no direct chemical interaction between alcohol and Phleum Pratense Top. However, alcohol consumption can sometimes exacerbate allergic symptoms or mask the early signs of an allergic reaction. It is generally advised to avoid alcohol around the time of the daily dose.
If treatment is discontinued for more than a few days, the patient should not restart at home. They must contact their allergist to determine if a supervised 're-entry' dose is required. Sudden discontinuation does not cause a withdrawal syndrome, but it will lead to a loss of the immunological progress made toward desensitization.
> Important: Discuss all your medical conditions, especially any history of asthma or severe allergic reactions, with your healthcare provider before starting Phleum Pratense Top.
There are no drugs that are strictly 'contraindicated' due to a chemical reaction with Phleum Pratense Top, but there are drugs that make the management of its side effects dangerous:
Phleum Pratense Top will significantly affect the results of:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, heart conditions, or depression.
Phleum Pratense Top must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients sensitive to Phleum Pratense Top are highly likely to be sensitive to other members of the Poaceae family, including Orchard grass, Perennial Rye grass, Kentucky Blue grass, and Red Top grass. While this cross-sensitivity is the basis for the drug's broad efficacy against various grasses, it also means that exposure to these other pollens during the treatment period can increase the cumulative 'allergen load' and the risk of side effects.
> Important: Your healthcare provider will evaluate your complete medical history, including lung function tests, before prescribing Phleum Pratense Top.
Phleum Pratense Top is categorized as Pregnancy Category B (under the older FDA system). There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not shown evidence of fetal harm.
It is not known whether the allergenic proteins or their metabolites are excreted in human milk. Because the proteins are digested in the gastrointestinal tract, systemic exposure to the nursing infant is unlikely. The decision to continue breastfeeding while taking Phleum Pratense Top should consider the mother's clinical need for the drug and any potential risk to the infant.
Phleum Pratense Top is approved for children ages 5 and older.
Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of concomitant diseases (like heart disease or hypertension) and the use of medications like beta-blockers that could complicate the treatment of an allergic reaction.
No dosage adjustment is required for patients with renal impairment. The allergenic proteins are not cleared by the kidneys in a way that would lead to toxicity in the presence of renal failure. However, severe renal disease may impair a patient's physiological 'reserve' to survive a systemic allergic reaction.
No dosage adjustment is required for patients with hepatic impairment. The liver is not involved in the primary clearance or metabolism of the allergenic proteins found in Phleum Pratense Top.
> Important: Special populations require individualized medical assessment and closer monitoring by an allergy specialist.
Phleum Pratense Top acts as a biological modifier of the immune response. It targets the underlying cause of Type I hypersensitivity. Upon sublingual administration, the major allergens (Phl p 1, Phl p 5) are captured by oral Langerhans cells. These cells migrate to local lymph nodes and present the allergen to naive T-cells. This process promotes the differentiation of T-regulatory (Treg) cells. These Tregs produce IL-10, which suppresses Th2-cell activity and induces B-cells to switch from producing IgE (the 'allergy' antibody) to IgG4 (the 'blocking' antibody). This shift reduces the activation of mast cells and basophils during subsequent environmental exposure to grass pollen.
The pharmacodynamic effect is measured by changes in the immune system rather than immediate physiological changes.
| Parameter | Value |
|---|---|
| Bioavailability | Low (primarily mucosal uptake) |
| Protein Binding | N/A (allergenic proteins) |
| Half-life | Hours (local tissue persistence) |
| Tmax | Immediate (mucosal contact) |
| Metabolism | Local Proteolysis |
| Excretion | Renal (as small peptides/amino acids) |
Phleum Pratense Top is a standardized extract containing both the water-soluble and protein components of Timothy Grass pollen. The extract is lyophilized (freeze-dried) into a tablet form.
It is classified as a Standardized Pollen Allergenic Extract. It is distinct from antihistamines and nasal steroids because it is the only treatment class capable of altering the natural course of the allergic disease.
Common questions about Phleum Pratense Top
Phleum Pratense Top is a standardized allergenic extract used specifically for allergen immunotherapy to treat seasonal allergic rhinitis caused by Timothy Grass pollen. It is intended for patients who have confirmed grass allergies through skin or blood testing and whose symptoms are not well-controlled by standard medications. By exposing the body to small, daily doses of the pollen extract, the treatment helps the immune system become less sensitive over time. This can lead to a significant reduction in symptoms like sneezing, congestion, and itchy eyes. It is approved for use in both adults and children as young as five years old.
The most common side effects are localized to the area where the medication is administered, which is the mouth and throat. Patients frequently report an itchy mouth (oral pruritus), a scratchy throat, or mild swelling of the tongue and gums shortly after taking the tablet. Some individuals may also experience itching in the ears or a tingling sensation in the mouth. These reactions are usually mild and tend to happen most often during the first week of treatment. Most local side effects resolve on their own within 30 to 60 minutes and become less frequent as the body adjusts to the medication.
There is no known direct chemical interaction between Phleum Pratense Top and alcohol. However, healthcare providers generally advise caution because alcohol can sometimes worsen allergic symptoms or cause flushing, which might be confused with an allergic reaction. Furthermore, alcohol could potentially impair your ability to recognize the early signs of a serious systemic reaction or your ability to use an epinephrine auto-injector. It is best to avoid drinking alcohol for at least a few hours before and after taking your daily dose. Always consult your doctor for personalized advice regarding alcohol use during immunotherapy.
Phleum Pratense Top is generally not started during pregnancy because of the risk of a severe allergic reaction (anaphylaxis), which could be dangerous for both the mother and the developing fetus. However, if a woman is already on a stable maintenance dose and is tolerating the medication well before becoming pregnant, her doctor may decide to continue the treatment. The primary concern is not the medication itself, but the potential for a systemic reaction that could lead to low oxygen levels for the baby. If you are planning to become pregnant or find out you are pregnant while taking this medication, you should notify your allergist immediately. A careful risk-benefit analysis is required for each individual case.
Phleum Pratense Top does not provide immediate relief like an antihistamine; it is a long-term treatment designed to change the immune system. Most patients need to start the medication at least 12 weeks before the grass pollen season begins to see benefits during that first season. While some immunological changes happen quickly, the full clinical effect is typically realized after several months of consistent daily use. For the best long-term results, including the possibility of remaining symptom-free after the treatment is stopped, a full three-year course of therapy is usually recommended. Consistency is key to the success of this immunotherapy.
You can stop taking Phleum Pratense Top without experiencing withdrawal symptoms, but doing so will interrupt the desensitization process. If you stop the medication for more than a few days, your immune system may lose its 'familiarity' with the allergen, which could increase the risk of a reaction when you restart. If you miss several doses, you should not simply start taking it again at home. Instead, contact your healthcare provider for instructions. They may want you to take the next dose in their office to ensure it is still safe for you to continue the treatment.
If you miss a single dose of Phleum Pratense Top, take it as soon as you remember on that same day. If you don't realize you missed the dose until the next day, skip the missed dose entirely and take your regularly scheduled dose. You should never take two doses in one day to make up for a missed one. If you miss more than one or two days in a row, it is important to call your doctor before resuming. Regular daily dosing is essential for both the safety and the effectiveness of the treatment.
There is no clinical evidence to suggest that Phleum Pratense Top causes weight gain. The medication consists of allergenic proteins and inactive ingredients like gelatin and mannitol, which do not have metabolic effects that would lead to weight changes. Unlike systemic corticosteroids, which are sometimes used for allergies and are known to cause weight gain, Phleum Pratense Top works through a localized immunological mechanism. If you experience unexpected weight changes while on this medication, you should discuss them with your healthcare provider to identify other potential causes. Your doctor can help determine if the change is related to other medications or health conditions.
Phleum Pratense Top can be taken alongside most common allergy medications like antihistamines and nasal steroids, which may actually help manage local side effects in the beginning. However, it can have dangerous interactions with certain other drugs, such as beta-blockers used for heart conditions or blood pressure. Beta-blockers can prevent epinephrine from working correctly if you have a severe allergic reaction. You must also inform your doctor if you are taking antidepressants like MAOIs or TCAs. Always provide your healthcare provider with a complete list of all medications and supplements you are using before starting immunotherapy.
Currently, Phleum Pratense Top is not available as a generic medication. It is a complex biological product that is marketed under specific brand names like GRASTEK. Because it is a standardized allergenic extract, the manufacturing process is highly regulated to ensure that each tablet contains a precise amount of the active pollen proteins. While generic versions of many drugs exist, biological products like these often require a different regulatory pathway for approval. You should discuss the cost and insurance coverage for the branded versions of this medication with your healthcare provider or pharmacist.